top of page

Our Mission
Solutions to address severe allergy epidemics with the market’s first double-dosing injector to address patients at-risk of allergy induced anaphylaxis.
News
-
May 2021- Patent allowed granting AllerMED Pharmaceuticals proprietary rights for the only double-dosing injector.
bottom of page